ASAC Trial: Aspirin Fails to Improve Colorectal Cancer Survival
Aspirin fails to lower the risk of cancer recurrence when administered after curative-intent treatment for colorectal cancer liver metastases, according to final phase 3 trial results published in The Lancet Gastroenterology & Hepatology. The Scandinavian ASAC trial tracked 428 patients across 14 hospitals in Norway, Sweden, and Denmark to test whether the inexpensive, widely available … Read more